用维布妥昔单抗治疗的阴道ALK阳性间变性大细胞淋巴瘤：一例报告及文献综述 - Suppr

Suppr

超能文献

Vaginal ALK-positive anaplastic large cell lymphoma treated with brentuximab vedotin: a case report and literature review.

作者信息

Cortez Anita Cassoli, Costa Felipe D'Almeida, Maira Bueno Silveira Talita

机构信息

AC Camargo Cancer Center, São Paulo, SP, Brazil.

出版信息

Hematol Transfus Cell Ther. 2022 Jul-Sep;44(3):456-458. doi: 10.1016/j.htct.2022.01.008. Epub 2022 Feb 16.

DOI:10.1016/j.htct.2022.01.008

PMID:35256331

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9477778/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ec/9477778/4f6947be3622/gr1.jpg

相似文献

Vaginal ALK-positive anaplastic large cell lymphoma treated with brentuximab vedotin: a case report and literature review.用维布妥昔单抗治疗的阴道ALK阳性间变性大细胞淋巴瘤：一例报告及文献综述

Hematol Transfus Cell Ther. 2022 Jul-Sep;44(3):456-458. doi: 10.1016/j.htct.2022.01.008. Epub 2022 Feb 16.

Complete response in a critically ill patient with ALK-negative anaplastic large cell lymphoma treated with single agent brentuximab-vedotin.单药本妥昔单抗治疗ALK阴性间变性大细胞淋巴瘤的危重症患者获得完全缓解。

Expert Rev Anticancer Ther. 2016;16(3):279-83. doi: 10.1586/14737140.2016.1146597. Epub 2016 Feb 18.

Brentuximab vedotin and crizotinib in anaplastic large-cell lymphoma.本妥昔单抗维布妥昔单抗与克唑替尼治疗间变大细胞淋巴瘤。

Cancer J. 2012 Sep-Oct;18(5):450-6. doi: 10.1097/PPO.0b013e31826aef4a.

Brentuximab vedotin for refractory anaplastic lymphoma kinase-negative anaplastic large cell lymphoma in leukemic phase with overexpression.维布妥昔单抗用于治疗处于白血病期且存在过表达的难治性间变性淋巴瘤激酶阴性间变性大细胞淋巴瘤。

Hematol Rep. 2020 May 15;12(1):8368. doi: 10.4081/hr.2020.8368. eCollection 2020 May 6.

Primary Cutaneous CD30+/ALK- ALCL with Transition into sALCL: Favourable Response after Systemic Administration with Brentuximab Vedotin! Unique Presentation in a Bulgarian Patient!原发性皮肤CD30+/ALK-间变性大细胞淋巴瘤转变为系统性间变性大细胞淋巴瘤：使用维布妥昔单抗全身给药后反应良好！保加利亚一名患者的独特病例！

Open Access Maced J Med Sci. 2018 Jul 12;6(7):1275-1277. doi: 10.3889/oamjms.2018.289. eCollection 2018 Jul 20.

[Successful alectinib monotherapy for residual disease after brentuximab vedotin combined chemotherapy in ALK-positive anaplastic large cell lymphoma].

Rinsho Ketsueki. 2022;63(8):855-859. doi: 10.11406/rinketsu.63.855.

The European Medicines Agency Review of Brentuximab Vedotin (Adcetris) for the Treatment of Adult Patients With Relapsed or Refractory CD30+ Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use.欧洲药品管理局对用于治疗复发或难治性CD30+霍奇金淋巴瘤或系统性间变性大细胞淋巴瘤成年患者的本妥昔单抗（安适利）的审评：人用药品委员会科学评估总结

Oncologist. 2016 Jan;21(1):102-9. doi: 10.1634/theoncologist.2015-0276. Epub 2015 Nov 30.

Case Report: Brentuximab Vedotin Associated Acute Pancreatitis in a Pediatric Hodgkin Lymphoma Patient: Case Report and Literature Review.病例报告：儿童霍奇金淋巴瘤患者接受 Brentuximab Vedotin 治疗后发生急性胰腺炎：病例报告及文献复习。

Pathol Oncol Res. 2022 Aug 12;28:1610445. doi: 10.3389/pore.2022.1610445. eCollection 2022.

Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1-2 trial.本妥昔单抗维迪西妥单抗联合苯达莫司汀治疗复发或难治性霍奇金淋巴瘤的国际多中心单臂 1/2 期临床试验。

Lancet Oncol. 2018 Feb;19(2):257-266. doi: 10.1016/S1470-2045(17)30912-9. Epub 2017 Dec 21.

Severe cytokine release syndrome after the first dose of Brentuximab Vedotin in a patient with relapsed systemic anaplastic large cell lymphoma (sALCL): a case report and review of literature.一例复发系统性间变性大细胞淋巴瘤（sALCL）患者首次使用维布妥昔单抗后发生严重细胞因子释放综合征：病例报告及文献复习

Eur J Haematol. 2015 Jun;94(6):554-7. doi: 10.1111/ejh.12396. Epub 2014 Jul 2.

引用本文的文献

Disseminated Anaplastic Lymphoma Kinase (ALK)-Positive T-cell Lymphoma Involving the Uterus and Cervix: A Case Report.弥漫性间变性淋巴瘤激酶（ALK）阳性T细胞淋巴瘤累及子宫和宫颈：一例报告

Cureus. 2024 Jan 23;16(1):e52815. doi: 10.7759/cureus.52815. eCollection 2024 Jan.

本文引用的文献

An Enteropathy-like Indolent NK-Cell Proliferation Presenting in the Female Genital Tract.女性生殖道惰性 NK 细胞增殖病样病变。

Am J Surg Pathol. 2020 Apr;44(4):561-565. doi: 10.1097/PAS.0000000000001387.

[Primary peripheral T-cell lymphoma of the vagina incidentally found at cervical cancer screening].

Rinsho Ketsueki. 2016 Jan;57(1):20-4. doi: 10.11406/rinketsu.57.20.

Primary T-Cell Non-Hodgkin Lymphoma of the Vagina.原发性阴道T细胞非霍奇金淋巴瘤

Case Rep Obstet Gynecol. 2015;2015:893083. doi: 10.1155/2015/893083. Epub 2015 May 26.

Primary extranodal non-Hodgkin's lymphoma of the vagina: a case report and a review of the literature.阴道原发性结外非霍奇金淋巴瘤：病例报告及文献复习。

Acta Haematol. 2012;128(1):33-8. doi: 10.1159/000337336. Epub 2012 May 15.

Lymphomas of the female genital tract: a study of 186 cases and review of the literature.女性生殖道淋巴瘤：186例病例研究及文献综述

Am J Surg Pathol. 2005 Nov;29(11):1512-20. doi: 10.1097/01.pas.0000178089.77018.a9.

Peripheral T/natural killer-cell lymphoma involving the female genital tract: a clinicopathologic study of 5 cases.累及女性生殖道的外周T/自然杀伤细胞淋巴瘤：5例临床病理研究

Int J Hematol. 2001 Jan;73(1):108-14. doi: 10.1007/BF02981911.

The National Cancer Data Base report on non-Hodgkin's lymphoma.国家癌症数据库关于非霍奇金淋巴瘤的报告。

Cancer. 1997 Dec 15;80(12):2311-20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验